MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaip.2026.04.022

Медицинская библиотека · The journal of allergy and clinical immunology. In practice · 2026

The Relationship Between Maternal Nonnarcotic Analgesics Allergy Labels and Maternal and Fetal Outcomes: Results From a Large Administrative Cohort.

Su Chang, Baer Rebecca J, Schatz Michael, Chambers Christina

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Nonnarcotic analgesics are the recommended first-line treatment for postpartum pain, and low-dose aspirin is recommended in approximately 85% of pregnant patients who have preeclampsia risk factors. Timely evaluation of nonnarcotic analgesics allergy labels (NNAALs) is essential for high-quality perinatal care.

OBJECTIVE

To address a knowledge gap in the relationship between maternal NNAALs and maternal and fetal outcomes.

METHODS

A retrospective analysis was conducted using the Study of Outcomes in Mothers and Infants, a population-based cohort of all births in California between 2016 and 2021. Maternal and fetal outcomes were examined by NNAAL status using Poisson log-linear regression to calculate adjusted relative risks (aRRs), 95% confidence intervals (CIs), and P values adjusted for maternal characteristics.

RESULTS

Maternal NNAALs were significantly associated with increased rates of preeclampsia (aRR, 1.16; P < .0001) and eclampsia (aRR, 1.64; P = .0047), cesarean delivery (aRR, 1.2; P < .0001), preterm birth (aRR, 1.17; P < .0001), infants with neonatal intensive care unit admission (aRR, 1.09; P = .0076), neonatal opioid withdrawal syndrome (aRR, 1.49; P < .0001), infant long length of hospital stay (aRR, 1.16; P < .0001), and a decreased rate of infants large for gestational age (aRR, 0.92; P = .0092), but were not associated with infants small for gestational age, major structural birth defects, or 5-minute Apgar score less than 7.

CONCLUSIONS

Maternal NNAALs were significantly associated with various maternal and fetal adverse outcomes. Our data suggest that proactive evaluations of patients with NNAALs may improve perinatal outcomes.

Для цитирования: Su Chang, Baer Rebecca J, Schatz Michael, Chambers Christina. The Relationship Between Maternal Nonnarcotic Analgesics Allergy Labels and Maternal and Fetal Outcomes: Results From a Large Administrative Cohort.. The journal of allergy and clinical immunology. In practice. 2026. DOI: 10.1016/j.jaip.2026.04.022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.